Bioreactors

Global Algal Oils Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 9, 2021
Retail, Alternative medicine, Health, Food, Beverage, Academic disciplines, Sustainable technologies, Algae fuel, Biochemical engineering, Bioreactors, Renewable energy, Sustainable energy, Compound annual growth rate, Dietary supplement, Algae, Sustainable development

The "Algal Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Algal Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Dietary Supplements, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$1.3 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $266 Million, While China is Forecast to Grow at 18.2% CAGR
    The Algal Oils market in the U.S. is estimated at US$266 Million in the year 2020.
  • In the global Other End-Uses segment, USA, Canada, Japan, China and Europe will drive the 11.9% CAGR estimated for this segment.

DIC Invests in Israeli Biotech Startup Vaxa Technologies

Retrieved on: 
Wednesday, April 28, 2021
Chemicals, Plastics, Fitness & Nutrition, Professional services, Manufacturing, Small business, Biotechnology, Food, Beverage, Health, Retail, Bioreactors, Algaculture, Photobioreactor, DIC Corporation, DIC Entertainment, Animation studios, Companies

b"DIC Corporation (TOKYO:4631) has completed investment in Vaxa Technologies Ltd., a biotech startup headquartered in Rosh Pina, Israel, as part of a strategic expansion of DIC businesses around health food and other algae-derived products.\nVaxa Technologies possesses unique proprietary light-emitting diode (LED) illuminated photobioreactors and algae cultivation technologies and is engaged in the development and commercialization of clean, unparalleled high-value-added algae products.

Key Points: 
  • b"DIC Corporation (TOKYO:4631) has completed investment in Vaxa Technologies Ltd., a biotech startup headquartered in Rosh Pina, Israel, as part of a strategic expansion of DIC businesses around health food and other algae-derived products.\nVaxa Technologies possesses unique proprietary light-emitting diode (LED) illuminated photobioreactors and algae cultivation technologies and is engaged in the development and commercialization of clean, unparalleled high-value-added algae products.
  • Vaxa Technologies\xe2\x80\x99 cultivation process employs renewable energy, achieving excellent productivity while consuming significantly less land and fresh water than conventional cultivation methods.
  • The DIC Group portfolio is organized into three segments: Packaging & Graphic, Color & Display, and Functional Products notably for electronic, automotive, and building materials.
  • The DIC Group is constantly working to promote and develop sustainable solutions to exceed customer expectations and better the world around us.

Yemoja Launches Skin-Deep Beauty with Microalgae Bioactive Ingredient

Retrieved on: 
Monday, April 12, 2021
Bioreactors, Branches of biology, Algaculture, Photobioreactor, Dietary Supplements, Microalgae, Biology, Marine biology, Algae, Red algae, Porphyridium cruentum

b'TEL HAI, Israel, April 12, 2021 /PRNewswire/ -- Marine cultivation start-up Yemoja, Ltd., introduces its algae-derived external polysaccharide sulphate (EPS) serving the skin-deep beauty sector.

Key Points: 
  • b'TEL HAI, Israel, April 12, 2021 /PRNewswire/ -- Marine cultivation start-up Yemoja, Ltd., introduces its algae-derived external polysaccharide sulphate (EPS) serving the skin-deep beauty sector.
  • This topicallyappliedbioactive ingredient from the Porphyridium cruentumspecies of microalgae is in high demand by the cosmetics industry for its naturally tendering anti-aging, anti-inflammatory, and rejuvenating properties.\nThe ingredient, branded EPS-Revive, is the first bio-active ingredient to be produced from the red algae in a tightly controlled lab environment using high-precision and fast-track photobioreactor technology.
  • This is driving the discovery and research of new natural compounds within the marine biosphere.
  • "While the demand for the product is high, Yemoja is a rare player in that we can provide a steady supply of the valuable and standardized raw material.

Yemoja Launches Skin-Deep Beauty with Microalgae Bioactive Ingredient

Retrieved on: 
Monday, April 12, 2021
Bioreactors, Branches of biology, Algaculture, Photobioreactor, Dietary Supplements, Microalgae, Biology, Marine biology, Algae, Red algae, Porphyridium cruentum

b'TEL HAI, Israel, April 12, 2021 /PRNewswire/ -- Marine cultivation start-up Yemoja, Ltd., introduces its algae-derived external polysaccharide sulphate (EPS) serving the skin-deep beauty sector.

Key Points: 
  • b'TEL HAI, Israel, April 12, 2021 /PRNewswire/ -- Marine cultivation start-up Yemoja, Ltd., introduces its algae-derived external polysaccharide sulphate (EPS) serving the skin-deep beauty sector.
  • This topicallyappliedbioactive ingredient from the Porphyridium cruentumspecies of microalgae is in high demand by the cosmetics industry for its naturally tendering anti-aging, anti-inflammatory, and rejuvenating properties.\nThe ingredient, branded EPS-Revive, is the first bio-active ingredient to be produced from the red algae in a tightly controlled lab environment using high-precision and fast-track photobioreactor technology.
  • This is driving the discovery and research of new natural compounds within the marine biosphere.
  • "While the demand for the product is high, Yemoja is a rare player in that we can provide a steady supply of the valuable and standardized raw material.

Outlook on the Single-Use Bioreactors Global Market to 2030 - Featuring Cytiva, Merck Millipore & Pall Among Others

Retrieved on: 
Tuesday, April 6, 2021
Life sciences, Biotechnology, Bioreactors, Single-use bioreactor, Biological engineering, Biopharmaceutical

To date, many biopharmaceutical companies and contract service providers have upgraded their manufacturing infrastructure and facilities to include more of single-use systems.

Key Points: 
  • To date, many biopharmaceutical companies and contract service providers have upgraded their manufacturing infrastructure and facilities to include more of single-use systems.
  • In addition, there are a number of companies that are now involved in the development and production of single-use bioreactors.
  • The report features an extensive study of the current landscape and the likely future potential of single-use bioreactors, over the next decade.
  • Elaborate profiles of prominent players (shortlisted based on number of products being offered) engaged in the development of single-use bioreactors.

Worldwide Single-use Bioreactors Industry to 2030 - Market Trends and Global Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 30, 2021
Health, Biotechnology, Bioreactors, Life sciences, Biotechnology, Biological engineering, Single-use bioreactor, Biology

The "Single-Use Bioreactors Market by Type of Reactor, Cell Culture System, End-User, and Geography: Industry Trends and Global Forecasts, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Single-Use Bioreactors Market by Type of Reactor, Cell Culture System, End-User, and Geography: Industry Trends and Global Forecasts, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • The report features an extensive study of the current landscape and the likely future potential of single-use bioreactors, over the next decade.
  • The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.
  • In addition, there are a number of companies that are now involved in the development and production of single-use bioreactors.

At 15.13% CAGR, Single-Use Bioreactor Market is expected to reach USD 4.50 Billion by 2027 Says Brandessence Market Research

Retrieved on: 
Wednesday, February 24, 2021
Bioreactors, Life sciences, Biotechnology, Biology, Biochemical engineering, Biological engineering, Single-use bioreactor, Market segmentation, Vaccine, Membrane bioreactor, Hollow fiber bioreactor

Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.

Key Points: 
  • Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.
  • The disposable bioreactor has a disposable bag instead of culture vessel which is known as Single-Use Bioreactor.
  • Single-Use Bioreactor Market Segmentation Analysis:
    Global Single-Use Bioreactor Market report is segmented on the basis of construction, mode, sizes, applications and region & country level.
  • The major factors driving the growth of global Single-Use Bioreactor market is rising in demand of effective vaccines and medications.

At 15.13% CAGR, Single-Use Bioreactor Market is expected to reach USD 4.50 Billion by 2027 Says Brandessence Market Research

Retrieved on: 
Wednesday, February 24, 2021
Bioreactors, Life sciences, Biotechnology, Biology, Biochemical engineering, Biological engineering, Single-use bioreactor, Market segmentation, Vaccine, Membrane bioreactor, Hollow fiber bioreactor

Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.

Key Points: 
  • Demand in Efficient Vaccines is a key driving factor for the growth of Single-Use Bioreactor Market.
  • The disposable bioreactor has a disposable bag instead of culture vessel which is known as Single-Use Bioreactor.
  • Single-Use Bioreactor Market Segmentation Analysis:
    Global Single-Use Bioreactor Market report is segmented on the basis of construction, mode, sizes, applications and region & country level.
  • The major factors driving the growth of global Single-Use Bioreactor market is rising in demand of effective vaccines and medications.

Europe Hydraulic Filters Market Forecast Report 2020-2027: Market Opportunities in the Evolution of Hydraulic Filters Along with Cyclone Effect Advancements - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 18, 2021
Construction & Property, Other Construction & Property, Photographic filter, Environmental engineering, Bioreactors

Europe Hydraulic Filters Market is expected to reach US$ 1,914.10 million by 2027 from US$ 1,020.54 million in 2019.

Key Points: 
  • Europe Hydraulic Filters Market is expected to reach US$ 1,914.10 million by 2027 from US$ 1,020.54 million in 2019.
  • Rising expenditure in the construction industry is the major factor driving the growth of the Europe hydraulic filters market.
  • However, issues associated with intricate installation process and steady design process to slow down the growth of hydraulic filters market in Europe.
  • The Europe hydraulic filters market is segmented based on the product and end-user.

Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality

Retrieved on: 
Monday, February 1, 2021
Data management, Biotechnology, Technology, Manufacturing, Health, Pharmaceutical, Research, Other Manufacturing, Software, Networks, Science, Biotechnology, Life sciences, Bioreactors, Articles, Biology, Biological engineering, Biochemical engineering, Fed-batch culture, Smart manufacturing, Predictive analytics, Single-use bioreactor

Aizon launches its Bioreactor Application, the pharma industrys first predictive analysis and deep knowledge management application.

Key Points: 
  • Aizon launches its Bioreactor Application, the pharma industrys first predictive analysis and deep knowledge management application.
  • The Aizon Bioreactor Application adds the bioreactor process to the Smart Manufacturing transformation that is accelerating across the Pharma and Biotech industry.
  • Designed to work with both continuous and fed-batch bioreactors, the Aizon Bioreactor Application provides a deep understanding of the customers bioprocess manufacturing lifecycle.
  • AI models for bioreactor analytics are ready for use within the application or can be configured by customers within the GxP cloud-based application.